Post by icemandios on May 10, 2021 23:53:03 GMT
Xeris Pharmaceuticals to Webcast Upcoming Presentations
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable drug formulations, today announced that Paul R. Edick, Chairman and Chief Executive Officer of Xeris Pharmaceuticals, will participate in following upcoming virtual events:
The diaTribe Foundation Musings: Taking the Fear out of Hypoglycemia: Next-Generation Glucagon on May 13, 2021
RBC Capital Markets Global Healthcare Conference on May 19, 2021
Jefferies Global Healthcare Conference on June 2, 2021
The presentations can be accessed by visiting âUpcoming Eventsâ on the Company's website at www.xerispharma.com .
The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check www.xerispharma.com for the latest information.
About Xeris Pharmaceuticals, Inc.
Xeris (Nasdaq: XERS) is a specialty pharmaceutical company delivering innovative solutions to simplify the experience of administering important therapies that people rely on every day around the world.
With a novel technology platform that enables ready-to-use, room-temperature stable formulations of injectable and infusible therapies, the company is advancing a portfolio of solutions in various therapeutic categories, including its first commercial products, GvokeÂŽ in the U.S. Its proprietary XeriSol⢠and XeriJect⢠formulation technologies have the potential to offer distinct advantages over conventional product formulations, including eliminating the need for reconstitution, enabling long-term, room-temperature stability, significantly reducing injection volume, and eliminating the requirement for intravenous (IV) infusion. With Xerisâ technology, new product formulations are designed to be easier to use by patients, caregivers, and health practitioners and help reduce costs for payers and the healthcare system.
Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com , or follow Xeris on Twitter, LinkedIn, or Instagram.
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable drug formulations, today announced that Paul R. Edick, Chairman and Chief Executive Officer of Xeris Pharmaceuticals, will participate in following upcoming virtual events:
The diaTribe Foundation Musings: Taking the Fear out of Hypoglycemia: Next-Generation Glucagon on May 13, 2021
RBC Capital Markets Global Healthcare Conference on May 19, 2021
Jefferies Global Healthcare Conference on June 2, 2021
The presentations can be accessed by visiting âUpcoming Eventsâ on the Company's website at www.xerispharma.com .
The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company's website. Please check www.xerispharma.com for the latest information.
About Xeris Pharmaceuticals, Inc.
Xeris (Nasdaq: XERS) is a specialty pharmaceutical company delivering innovative solutions to simplify the experience of administering important therapies that people rely on every day around the world.
With a novel technology platform that enables ready-to-use, room-temperature stable formulations of injectable and infusible therapies, the company is advancing a portfolio of solutions in various therapeutic categories, including its first commercial products, GvokeÂŽ in the U.S. Its proprietary XeriSol⢠and XeriJect⢠formulation technologies have the potential to offer distinct advantages over conventional product formulations, including eliminating the need for reconstitution, enabling long-term, room-temperature stability, significantly reducing injection volume, and eliminating the requirement for intravenous (IV) infusion. With Xerisâ technology, new product formulations are designed to be easier to use by patients, caregivers, and health practitioners and help reduce costs for payers and the healthcare system.
Xeris is headquartered in Chicago, IL. For more information, visit www.xerispharma.com , or follow Xeris on Twitter, LinkedIn, or Instagram.